Highlights Liaoning Chengda Biotechnology Co.,Ltd.

Equities

688739

CNE100004ZP2

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
27.29 ^CNY	+0.59%		-0.58%	-16.06%

05-20	Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets	MT
04-29	Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets	05-20	MT
Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.	04-01	CI
Hong Kong-listed Samsonite plans dual listing in hunt for investors	03-22	RE
Hong Kong Shares Inch Up After China Holds Benchmark Rates Steady; Qyuns Therapeutics Falls 9% on Debut	03-20	MT
Li Ning's 2023 Profit Falls as Selling, Admin Costs Rise	03-20	MT
Global markets live: Domino's Pizza, Generali, Oracle, Intel, Boeing...	03-12
China's champion gymnast Li Ning considers taking company private, sources say	03-12	RE
China's champion gymnast Li Ning considers taking company private, sources say	03-12	RE
CHINESE OLYMPIC CHAMPION LI NING CONSIDERS TAKING PRIV…	03-12	RE
Liaoning Chengda Biotechnology Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	03-11	CI
Liaoning Chengda Biotechnology Co.,Ltd. authorizes a Buyback Plan.	03-10	CI
Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
News Highlights : Top Company News of the Day	12-25	DJ
Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on September 18, 2023.	12-20	CI
Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback announced on September 18, 2023, has closed with 2,251,804 shares, for CNY 74.8 million.	12-20	CI
Li Ning to Buy HK Building for HK$2.2 Billion to House New HQ; Shares Up 4%	12-12	MT
Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Li Ning Logs Mid-Single-Digit Retail Sell-Through Growth in Q3	25/10/23	MT
Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on September 18, 2023.	09/10/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Liaoning Chengda Biotechnology Co.,Ltd.

Equities

688739

CNE100004ZP2

Highlights

Filters